|
Wellcome Trust Scottish Translational Medicine and Therapeutics Initiative - STMTI
Welcome to STMTI
STMTI is a novel collaboration between the four Scottish Academic Medical Centres,
funded by the Wellcome Trust, and with additional support from Pfizer
Pharmaceuticals in a PhD programme to create a new cadre of academic
clinicians with expertise in translational medicine and therapeutics.
STMTI
offers novel posts in the post-MMC environment that offer the potential
of ‘run-through’ PhD and clinical training for the aspiring academic
clinician.
STMTI Recruitment
The
latest round of recruitment is now live. For further information, see How to Apply. The closing date for
applications is Friday 6th April 2012.
To apply, click here.
WTCRF Translational Pharmacology Course
STMTI are organising a Translational Pharmacology Course
through the WTCRF Education Core. The course will be held in
Edinburgh between 25th and 29th June 2012. It is particularly
designed to teach the students on making the bridge between
pre-clinical pharmacology and first-in-man studies. There is only
a draft programme at the moment, but we plan a series of high profile
speakers. The programme will be amended accordingly as and when
speakers are confirmed. Click here to view the draft programme.
To register your interest in participating in this course, please send
an email to stmti@ed.ac.uk with your name, current position, email
address and a contact number.
STMTI and MRC SCP3 Joint Launch
A Consortium of Scottish Clinical Medical Schools (Universities of
Aberdeen, Dundee, Edinburgh and Glasgow) has recently been awarded
funding to support two innovative PhD fellowship training schemes for
clinicians. The first is STMTI, for which Fellows have already been
recruited in several centres, and we have launched our first
fellowships this year. The second is an award from the MRC, SCP3, for
training of clinical pharmacologists and pathologists in translational
research.
To mark these awards, we launched these initiatives, jointly, at the
University of Edinburgh’s Queen's Medical Research Institute on Monday,
22nd November, 2010. Professor Sir John Savill, MRC CEO-Elect,
hosted the day, and Professor Garret FitzGerald gave a keynote talk on
TMAT. Leaders of the other Wellcome Trust TMAT
centres also participated.
The speakers have kindly agreed to make copies of their presentations
available on this website. These may be helpful to those unable
to attend the Launch, and those who attended but would like a closer
look. To view the presentations, please click on the speakers'
names below:
Dr Peter Dukes - MRC
Professor Garret FitzGerald - University of Pennsylvania
Dr Allison Jeynes-Ellis - ABPI
Professor Iain McInnes - Director, SCP3/Deputy Director, STMTI
Professor David Webb - Director, STMTI/Deputy Director, SCP3
Professor Martin Wilkins - Imperial College
Dr John Williams - Wellcome Trust
Dr Steve Felstead - Pfizer
To view the programme, click here
For further information, please direct enquiries to stmti@ed.ac.uk
   
 
|
